Stem Cells for the Heart, Are We There Yet?
- 1 December 2003
- journal article
- review article
- Published by S. Karger AG in Cardiology
- Vol. 100 (4) , 176-185
- https://doi.org/10.1159/000074811
Abstract
Although several repair mechanisms have been described in the human heart, all fall too short to prevent clinical heart disease in most acute or chronic pathological cardiac conditions. Moreover, despite many breakthroughs in cardiovascular medicine, the complications of a myocardial infarction such as chronic heart failure remains a serious worldwide problem. Bone marrow stem cells could provide for a promising strategy to restore myocardial infarctions and prevent postinfarct congestive heart failure, because there is growing body of evidence that bone marrow stem cells, such as mesenchymal stem cells, can generate new cardiomyocytes in animals and humans. In this review, we will discuss important issues on stem cell therapy for cardiac regeneration after myocardial infarction, which might be of paramount importance when considering future human trials.This publication has 75 references indexed in Scilit:
- Mosquito production mooted as fast track to malaria vaccineNature, 2003
- Stem Cell Repair of Infarcted MyocardiumCirculation, 2003
- Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive LabelingCirculation, 2003
- Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectorsGene Therapy, 2003
- Heart Regeneration in ZebrafishScience, 2002
- Pluripotency and tumorigenicityNature Genetics, 2002
- The scarless heartSeminars in Cell & Developmental Biology, 2002
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Hematopoiesis and stem cells: plasticity versus developmental heterogeneityNature Immunology, 2002
- Regeneration of skeletal and cardiac muscle in mammals: do nonprimate models resemble human pathology?Wound Repair and Regeneration, 1999